Pharmaceutical News

RSS

Most commonly prescribed drugs to primary care patients are not often tested

Drugs most commonly prescribed to patients seen by primary care physicians are not often tested in the patients who go to these clinics, where most people receive their care, say investigators at Georgetown University Medical Center and Yale School of Medicine.

28 Aug 2018

Daily use of aspirin does not reduce occurrence of major cardiovascular events, finds ARRIVE trial

The role of aspirin in preventing a first heart attack or stroke among people at moderate risk of heart disease remains unclear.

28 Aug 2018

Amphetamine regimen does not improve post-stroke motor recovery

A pilot clinical trial exploring the benefit of d-amphetamine combined with physical therapy for stroke patients found no evidence that the regimen improved post-stroke motor recovery.

27 Aug 2018

Study shows new options to lower heart disease risk in people with diabetes

A drug used to manage diabetes may reduce heart disease and death in people with diabetes regardless of their cholesterol levels and whether they are on a statin therapy, suggests a new analysis of the LEADER trial.

27 Aug 2018

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and coronary artery disease, according to late breaking results from the COMMANDER HF trial presented today in a Hot Line Session at ESC Congress 2018 and with simultaneous publication in NEJM.

27 Aug 2018

Some breast cancers can prevent their own spread

Scientists have discovered a mechanism by which people with advanced breast cancer do not experience metastasis and live normal lives.

27 Aug 2018

Evotec collaborates with CENTOGENE to develop compounds to treat rare genetic diseases

CENTOGENE today announced that Evotec AG and CENTOGENE AG entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic diseases.

27 Aug 2018

Aspirin appears to cause major bleeds and have no effect on cancers

Aspirin prevented serious vascular events in patients with diabetes who did not already have cardiovascular disease, but it caused almost as many major bleeds and there was no effect on cancers.

27 Aug 2018

Study: 1 in 12 children taking multiple medications at risk of drug-drug interactions

According to new research from the University of Illinois at Chicago, about one in five children regularly use prescription medications, and nearly one in 12 of those children are at risk for experiencing a harmful drug-drug interaction.

27 Aug 2018

Study finds traces of marijuana in breast milk up to six days after use

With the legalization of marijuana in several states, increased use for both medicinal and recreational purposes has been documented in pregnant and breastfeeding women.

27 Aug 2018

Oral anticoagulant use after hospital discharge may offer protection from non-fatal blood clots

The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.

27 Aug 2018

ARRIVE study assesses impact of daily aspirin on heart attacks, strokes

The jury is still out on whether people at moderate risk of a first heart attack or stroke should take daily aspirin to lower their risk, according to late breaking results from the ARRIVE study presented today in a Hot Line Session at ESC Congress 2018 and with simultaneous publication in the Lancet.

27 Aug 2018

Weight loss pill Lorcaserin found to have low cardiovascular risk

Weight loss pills have been discovered and then withdrawn from the market because of the risks that they pose to the heart. Some of them have raised the risk of heart attacks, suicides, heart valve problems significantly and have been thus banned.

27 Aug 2018

$Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction$

Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction

Data from the TRANSITION study presented today at the European Society of Cardiology Congress in Munich, Germany has shown that Entresto® can be initiated early and safely in a wide range of heart failure patients with reduced ejection fraction who have been stabilized after hospitalization due to an acute heart failure episode.

25 Aug 2018

Peptilogics held pre-IND meeting with FDA to develop PLG0206 for treating prosthetic joint infections

Peptilogics, a development stage company utilizing its innovative peptide platform to treat multidrug-resistant bacterial infections, today announced it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration to discuss the regulatory pathway for the development of PLG0206 for the treatment of prosthetic joint infections.

25 Aug 2018

Patients with blood pressure must start treatment with two drugs as a single pill

A single pill with two drugs could transform blood pressure treatment, according to the 2018 European Society of Cardiology and European Society of Hypertension Guidelines on arterial hypertension published online today in European Heart Journal, and on the ESC website.

25 Aug 2018

Pharmaceutical News

Most commonly prescribed drugs to primary care patients are not often tested

Daily use of aspirin does not reduce occurrence of major cardiovascular events, finds ARRIVE trial

Amphetamine regimen does not improve post-stroke motor recovery

Study shows new options to lower heart disease risk in people with diabetes

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

Some breast cancers can prevent their own spread

Evotec collaborates with CENTOGENE to develop compounds to treat rare genetic diseases

Aspirin appears to cause major bleeds and have no effect on cancers

Study: 1 in 12 children taking multiple medications at risk of drug-drug interactions

Study finds traces of marijuana in breast milk up to six days after use

Oral anticoagulant use after hospital discharge may offer protection from non-fatal blood clots

ARRIVE study assesses impact of daily aspirin on heart attacks, strokes

Weight loss pill Lorcaserin found to have low cardiovascular risk

Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction

Peptilogics held pre-IND meeting with FDA to develop PLG0206 for treating prosthetic joint infections

Patients with blood pressure must start treatment with two drugs as a single pill

HU researchers develop new biological drug that may cure acute myeloid leukemia

Drug used to treat amoebic dysentery may block journey of rabies virus in nerves

Podcast: KHN’s ‘What the Health?’ Opioids, epipens and health funding

Wound healing work presented at the RCP Innovation in Medicine Conference 2018 by Neem Biotech

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News